AlloVir Statistics
Total Valuation
AlloVir has a market cap or net worth of $47.92 million. The enterprise value is -$73.93 million.
| Market Cap | 47.92M |
| Enterprise Value | -73.93M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025, before market open.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AlloVir has 4.98 million shares outstanding. The number of shares has increased by 16.29% in one year.
| Current Share Class | 4.98M |
| Shares Outstanding | 4.98M |
| Shares Change (YoY) | +16.29% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 18.15% |
| Owned by Institutions (%) | 15.18% |
| Float | 1.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 86.78
| Current Ratio | 86.78 |
| Quick Ratio | 86.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.33% and return on invested capital (ROIC) is -28.47%.
| Return on Equity (ROE) | -63.33% |
| Return on Assets (ROA) | -26.82% |
| Return on Invested Capital (ROIC) | -28.47% |
| Return on Capital Employed (ROCE) | -65.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$894,616 |
| Employee Count | 112 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -126,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.51% in the last 52 weeks. The beta is 0.64, so AlloVir's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -40.51% |
| 50-Day Moving Average | 10.08 |
| 200-Day Moving Average | 15.45 |
| Relative Strength Index (RSI) | 45.63 |
| Average Volume (20 Days) | 22,392 |
Short Selling Information
The latest short interest is 59,532, so 1.20% of the outstanding shares have been sold short.
| Short Interest | 59,532 |
| Short Previous Month | 1.59M |
| Short % of Shares Out | 1.20% |
| Short % of Float | 3.23% |
| Short Ratio (days to cover) | 26.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -79.57M |
| Pretax Income | -179.66M |
| Net Income | -100.20M |
| EBITDA | -79.13M |
| EBIT | -79.57M |
| Earnings Per Share (EPS) | -$20.07 |
Balance Sheet
| Cash & Cash Equivalents | 121.85M |
| Total Debt | n/a |
| Net Cash | 121.85M |
| Net Cash Per Share | $24.49 |
| Equity (Book Value) | 121.12M |
| Book Value Per Share | 24.37 |
| Working Capital | 121.12M |
Cash Flow
| Operating Cash Flow | -94.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -94.87M |
| FCF Per Share | -$19.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AlloVir does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.29% |
| Shareholder Yield | -16.29% |
| Earnings Yield | -209.11% |
| FCF Yield | -197.99% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 16, 2025. It was a reverse split with a ratio of 0.0434783:1.
| Last Split Date | Jan 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0434783:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |